Cox Christopher Nixon
CIK: 0002008212
Director
Primary company: Alto Neuroscience, Inc. (ANRO)
Cox Christopher Nixon is a corporate insider at Alto Neuroscience, Inc. (ANRO) filing SEC Form 4 transactions. 9 transactions across 2 companies. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 15,287 | - | - | 15,287 | 5/13/2025 Filed: 5/15/2025 | Filing → | |
Newsmax Inc. NMAX | Award | 17,500 | - | - | 17,500 | 3/28/2025 Filed: 4/4/2025 | Filing → |
| Award | 25,236 | $4.38 | $111K | 25,236 | 1/2/2025 Filed: 1/6/2025 | Filing → | |
| Conversion | 281,917 | - | - | 0 | 2/6/2024 Filed: 2/7/2024 | Filing → | |
| Conversion | 1,250,000 | - | - | 0 | 2/6/2024 Filed: 2/7/2024 | Filing → | |
| Conversion | 126,755 | - | - | 715,653 | 2/6/2024 Filed: 2/7/2024 | Filing → | |
| Conversion | 588,898 | - | - | 588,898 | 2/6/2024 Filed: 2/7/2024 | Filing → | |
| Award | 4,623 | $11.88 | $55K | 4,623 | 2/1/2024 Filed: 2/5/2024 | Filing → | |
| Award | 30,574 | - | - | 30,574 | 2/1/2024 Filed: 2/5/2024 | Filing → |
Type
Award
Shares
15,287
Price
-
Value
-
Newsmax Inc.
NMAX
Type
Award
Shares
17,500
Price
-
Value
-
Type
Award
Shares
25,236
Price
$4.38
Value
$111K
Type
Conversion
Shares
281,917
Price
-
Value
-
Type
Conversion
Shares
1,250,000
Price
-
Value
-
Type
Conversion
Shares
126,755
Price
-
Value
-
Type
Conversion
Shares
588,898
Price
-
Value
-
Type
Award
Shares
4,623
Price
$11.88
Value
$55K
Type
Award
Shares
30,574
Price
-
Value
-
AI Agent
Try asking...